Science

Latest Science News

📅February 16, 2026 at 1:00 PM
Breakthroughs in origins of life RNA, cancer enzymes and therapies, molecular glues for leukemia, CRISPR HIV removal, diabetes immune discoveries, and cosmic end scenarios dominate science news.
1

Scientists Discover Tiny Self-Replicating RNA Shedding Light on Life's Origins

Researchers at MRC Laboratory of Molecular Biology identified QT45, a small RNA molecule that copies itself and its strand, supporting RNA world hypothesis for life's start.Source 1 Its size allows spontaneous emergence, with team now aiming for full self-replication cycle.Source 1 Discovery implies life could arise on other planets.Source 1

2

Enzyme N4BP2 Identified as Trigger for Cancer's Chaotic DNA Rewiring

UC San Diego team found N4BP2 enzyme causes chromothripsis, shattering chromosomes in 25% of cancers, enabling tumor adaptation.Source 2Source 5 Blocking N4BP2 reduced DNA destruction in cancer cells dramatically.Source 2Source 5 This offers a new target to slow cancer evolution and resistance.Source 2Source 5

3

Large-Scale Molecular Glue Breakthrough for Leukemia Treatment

Teams from CeMM and Scripps developed high-throughput method generating thousands of variants to find glues degrading ENL protein in leukemia cells.Source 3Source 7 The compound selectively reduces leukemia growth via ubiquitin ligase recruitment.Source 3Source 7 Approach enables rational discovery of drugs for undruggable targets.Source 3Source 7

4

FDA Approves Optune Tumor Fields with Chemo for Pancreatic Cancer

US FDA approved Optune combined with chemotherapy for pancreatic cancer, expanding device-based treatments for this aggressive disease.Source 4 This diversifies therapeutic options beyond traditional therapies.Source 4 Approval marks progress in oncology modalities.Source 4

5

PATINA Trial Shows Palbociclib Improves Breast Cancer Survival

PATINA trial reported significant progression-free survival gains with palbociclib in advanced HR-positive breast cancer.Source 4 This reinforces CDK4/6 inhibitors' role in treatment.Source 4 Findings highlight continued advancements in breast oncology.Source 4

6

Nerves Found to Actively Fuel Pancreatic Cancer Growth

Scientists revealed pancreatic support cells attract nerve fibers forming dense networks around lesions via 3D imaging.Source 6 This uncovers nerve-cancer partnership driving tumor progression.Source 6 Published in Cancer Discovery.Source 6

7

SerpinB2 Discovery in Immune Cells Could Reverse Type 2 Diabetes

New research shows SerpinB2 enhances immune cells to fight insulin resistance in type 2 diabetes.Source 8 This breakthrough targets underlying immune mechanisms.Source 8 Potential for novel reversal therapies.Source 8

8

Chinese Scientists Use CRISPR to Remove HIV DNA from Infected Cells

Researchers successfully excised HIV from human cell DNA using CRISPR, a step toward potential cure beyond ART suppression.Source 9 Experts note promising lab results but need human trials for safety.Source 9 Findings hailed as major breakthrough.Source 9

9

New Dark Energy Data Suggests Universe May End in Big Crunch

Cornell analysis of dark energy observatories indicates universe expansion may reverse into big crunch, not eternal expansion.Source 11 This challenges prevailing cosmic models.Source 11 Data from February 16, 2026.Source 11

10

Plant Scientists Target New Wheat Pathogen with Ancient Collections

UK researchers explore ancient wheat varieties to combat emerging pathogen threatening crops.Source 1 This addresses major agricultural science challenge.Source 1 Dated February 13, 2026.Source 1

11

FDA Expands Pembrolizumab Use Across Oncology Indications

FDA broadened pembrolizumab approvals, strengthening immunotherapy's role in multiple tumor types.Source 4 Reinforces its dominance in cancer treatment lines.Source 4 Key regulatory milestone.Source 4

12

Low-Dose Immunotherapy Shows Promise in Reducing Toxicity

Emerging data indicates lower immunotherapy doses maintain efficacy while cutting toxicity and costs.Source 4 Could reshape protocols if validated.Source 4 Highlights dosing innovation.Source 4